State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery

Drug nanocrystals are the latest, broadly introduced nanoparticulate carrier to the pharmaceutical market from the year 2000 onwards. The special features of nanocrystals for the delivery of poorly soluble drugs are briefly reviewed (saturation solubility, dissolution velocity, adhesiveness). The in...

Full description

Bibliographic Details
Main Authors: Muller, Rainer Helmut, Gohla, Sven H., Keck, Cornelia M.
Format: Article
Language:English
Published: Elsevier 2011
Online Access:http://psasir.upm.edu.my/id/eprint/40025/
http://psasir.upm.edu.my/id/eprint/40025/1/State%20of%20the%20art%20of%20nanocrystals.pdf
_version_ 1848849308606005248
author Muller, Rainer Helmut
Gohla, Sven H.
Keck, Cornelia M.
author_facet Muller, Rainer Helmut
Gohla, Sven H.
Keck, Cornelia M.
author_sort Muller, Rainer Helmut
building UPM Institutional Repository
collection Online Access
description Drug nanocrystals are the latest, broadly introduced nanoparticulate carrier to the pharmaceutical market from the year 2000 onwards. The special features of nanocrystals for the delivery of poorly soluble drugs are briefly reviewed (saturation solubility, dissolution velocity, adhesiveness). The industrially relevant bottom up (precipitation) and top down production technologies (pearl milling, high pressure homogenization, combination technologies) are presented. As nanotoxicological aspects, the effect of size, degradability versus biopersistency and intracellular uptake are discussed, classifying the nanocrystals in the low/non-risk group. Intracellular uptake plays a minor or no role for dermal and oral nanocrystals, but it plays a key role for intravenously injected nanocrystals (e.g. nevirapine, paclitaxel, itraconazole). Uptake by the macrophages of the mononuclear phagocytic system (MPS, liver spleen) can modify/optimize blood profiles via prolonged release from the MPS (itraconazole), but also target toxicity by too high organ concentrations and thus cause nanotoxicity. The balance in the competitive intracellular uptake by MPS and the target cells (e.g. blood–brain barrier) decides about therapeutic efficiency. The concept of “differential protein adsorption” to modulate this balance is shown for its applicability to nanocrystals for intracellular delivery to the cells of the blood–brain barrier (atovaquone).
first_indexed 2025-11-15T09:48:20Z
format Article
id upm-40025
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T09:48:20Z
publishDate 2011
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling upm-400252015-08-27T00:20:13Z http://psasir.upm.edu.my/id/eprint/40025/ State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery Muller, Rainer Helmut Gohla, Sven H. Keck, Cornelia M. Drug nanocrystals are the latest, broadly introduced nanoparticulate carrier to the pharmaceutical market from the year 2000 onwards. The special features of nanocrystals for the delivery of poorly soluble drugs are briefly reviewed (saturation solubility, dissolution velocity, adhesiveness). The industrially relevant bottom up (precipitation) and top down production technologies (pearl milling, high pressure homogenization, combination technologies) are presented. As nanotoxicological aspects, the effect of size, degradability versus biopersistency and intracellular uptake are discussed, classifying the nanocrystals in the low/non-risk group. Intracellular uptake plays a minor or no role for dermal and oral nanocrystals, but it plays a key role for intravenously injected nanocrystals (e.g. nevirapine, paclitaxel, itraconazole). Uptake by the macrophages of the mononuclear phagocytic system (MPS, liver spleen) can modify/optimize blood profiles via prolonged release from the MPS (itraconazole), but also target toxicity by too high organ concentrations and thus cause nanotoxicity. The balance in the competitive intracellular uptake by MPS and the target cells (e.g. blood–brain barrier) decides about therapeutic efficiency. The concept of “differential protein adsorption” to modulate this balance is shown for its applicability to nanocrystals for intracellular delivery to the cells of the blood–brain barrier (atovaquone). Elsevier 2011-05 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/40025/1/State%20of%20the%20art%20of%20nanocrystals.pdf Muller, Rainer Helmut and Gohla, Sven H. and Keck, Cornelia M. (2011) State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery. European Journal of Pharmaceutics and Biopharmaceutics, 78 (1). pp. 1-9. ISSN 0939-6411; ESSN: 1873-3441 http://www.sciencedirect.com/science/article/pii/S0939641111000142 10.1016/j.ejpb.2011.01.007
spellingShingle Muller, Rainer Helmut
Gohla, Sven H.
Keck, Cornelia M.
State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery
title State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery
title_full State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery
title_fullStr State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery
title_full_unstemmed State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery
title_short State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery
title_sort state of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery
url http://psasir.upm.edu.my/id/eprint/40025/
http://psasir.upm.edu.my/id/eprint/40025/
http://psasir.upm.edu.my/id/eprint/40025/
http://psasir.upm.edu.my/id/eprint/40025/1/State%20of%20the%20art%20of%20nanocrystals.pdf